4//SEC Filing
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 4
Accession 0000950170-25-012574
CIK 0002040807other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:48 PM ET
Size
7.1 KB
Accession
0000950170-25-012574
Insider Transaction Report
Form 4
Metsera, Inc.MTSR
Transactions
- Conversion
Common Stock
2025-01-30+1,857,699→ 1,857,699 total - Conversion
Series B Preferred Stock
2025-01-30−4,365,079→ 0 total→ Common Stock (1,857,699 underlying)
Footnotes (1)
- [F1]Each share of Series B Preferred Stock automatically converted into Common Stock on a 2.349723-for-1 basis upon closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date.
Documents
Issuer
Metsera, Inc.
CIK 0002040807
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001903360
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 6:48 PM ET
- Size
- 7.1 KB